Manish Agrawal, Sunstone CEO

At Sunstone, safety and comfort extend far beyond the dosing room. Discover how our comprehensive care model protects both physical and psychological well-being through rigorous clinical evaluations, ongoing consent discussions, and dedicated post-dosing integration support.

Trauma-informed care (TIC) is essential to minimizing risks and maximizing growth during psychedelic therapy. Explore Sunstone’s patient-centered framework, where continuous informed consent, psychological safety, and individualized care are built into every step of the treatment process.

Sunstone Therapies is enrolling for SUN004, a Phase 2 study of psilocybin therapy for women with sexual assault-related PTSD. This trauma-informed trial utilizes a Shared Decision-Making framework to prioritize survivor agency and trust. Learn about our patient-led approach, which includes preparatory sessions, specialized therapeutic support, and optional long-term group integration.